CWRU and Haima Therapeutics Sign Option License to Develop SynthoPlate

Case Western Reserve University and Haima Therapeutics signed a two-year option to license a technology to prevent and treat bleeding complications from trauma, low platelet counts, and surgery.

Read More  >